Literature DB >> 27617238

Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action.

Fatemeh Abdi1, Hamid Mobedi2, Nasibeh Roozbeh3.   

Abstract

Menopause is a critical stage of women's life associated with various complaints and distresses. Vasomotor symptoms (VMS), such as hot flushes, night sweats, sleep disturbances, and fatigue, are the most common menopause symptoms affecting about 50% to 80% of middle-aged women. Obviously, these symptoms, resulting from estrogen deficiency during menopause, can exert negative effects on women's health and quality of life and thus require to be managed through approaches such as hormone replacement therapy (HRT). Many herbal treatments for menopause symptoms contain and its components such as 8-prenylnaringenin, 6-PN, isoxanthohumol and xanthohumol. Recent in-vivo studies have highlighted the ability of 8-prenylnaringenin to reduce serum-luteinizing hormone (LH) and follicle-stimulating hormone (FSH), to increase serum prolactin levels and uterine weight, and to induce vaginal hyperplastic epithelium. Previous research has shown that hops extract can strongly bind to both estrogen receptors, stimulate alkaline phosphatase activity in Ishikawa cells, and upregulate presenelin-2 and progesterone receptor mRNA in Ishikawa cells. Numerous clinical trials have documented significant reductions in the frequency of hot flushes following the administration of hop-containing preparations. Nevertheless, further clinical trials with larger sample size and longer follow-up are warranted to confirm such benefits.

Entities:  

Keywords:  Hormone replacement therapy; Hot flashes; Humulus; Menopause

Year:  2016        PMID: 27617238      PMCID: PMC5016504          DOI: 10.6118/jmm.2016.22.2.62

Source DB:  PubMed          Journal:  J Menopausal Med        ISSN: 2288-6478


Menopause, also known as the second puberty, is a crtiical stage of women's life associated with various complaints and distresses.1 Vasomotor symptoms (VMS), such as hot flushes, night sweats, sleep disturbances, and fatigue, are the most common menopause symptoms affecting about 50% to 80% of middle-aged women. Although VMS generally subside after five-seven years, some women have to deal with these symptoms for as long as 10 to 15 years.23 Along with psychological and physical effects, Menopause can also cause VMS and these symptoms can affect the quality of life. Obviously, these symptoms, resulting from estrogen deficiency during menopause, can exert negative effects on women's health and quality of life4 and thus require to be managed through approaches such as hormone replacement therapy (HRT). However, according to the Women's Health Initiative and other clinical trials, HRT can increase the risk of various health issues in postmenopausal women. Estrogen deficiency is associated with complaints that may increase the risks for both morbidity and mortality including increased cognitive changes and osteoporosis. For this reason, there is an interest in utilizing HRT in menopausal women.5 However, according to the Women's Health Initiative and other clinical trials, HRT can increase the risk of various health issues such as breast cancer, endometrial cancer, thromboembolism disorders, stroke and coronary heart disease in this population.6 Therefore, during the past decade, growing attention has been paid to the use of herbal medicines for the treatment of menopausal symptoms. Many herbal treatments for menopausal symptoms contain hops (Humulus lupulus L.) and its components such as 8-prenylnaringenin (8-PN; a potent phytoestrogen), 6-PN and isoxanthohumol (two well-known flavanones), and xanthohumol (a prenylated chalcone).7 The high estrogenic potency of 8-PN was confirmed by its ability to interact with estrogen receptors (ERs) in a radioligand binding assay on rat uterine cytosol. On the other hand 6-PN showed a very weak estrogenic activity as isoxanthoumol did, while xanthoumol was inactive.8 Eight-PN displayed two fold higher affinity for ER-alpha (ERα) than ER-beta (β) measured by in vitro competitive binding assay.9 Phytoestrogens are secondary metabolites of herbs and characterized by a polyphenolic structure with phenol rings. Phytoestrogens have similar structures with 17β-estradiol generated by the ovaries, and bind to ERs. Hops containing terpenoid, flavonoid glycoside and catechin are widely used to treat tension, headache, edema10 sleep disorders (through impact on the central nervous system), activating the stomach and appetite. Other beneficial effects of this plant is joint pain reducing, sedation, anxiety and nervousness reducing and effect on kidney. In recent years has been working on anticancer and estrogenic properties its.11 Despite its confirmed benefits, the mechanisms through which hops relieves menopausal symptoms are not clearly understood. Nevertheless, preparations based on hops have been found to decrease the severity and frequency of hot flushes.12 The frequent menstrual disturbances observed in female hop-pickers, during the early days of hop cones harvesting, suggested a potential hormonal activity of humulus lupulus.13 In two randomized placebo-controlled clinical trials performed by Erkkola et al.14 and Heyerick et al.15 on the efficacy of humulus lupulus, hot flushes, sweating, insomnia, palpitation and other VMS were identified to be declined. Recent in-vivo studies have highlighted the ability of 8-PN to reduce serum-luteinizing hormone (LH) and follicle-stimulating hormone (FSH), to increase serum prolactin levels and uterine weight, and to induce vaginal hyperplastic epithelium.16 Bowe et al.12 reported the efficacy of daily subcutaneous administration of 8-PN in decreasing elevated skin temperatures in a rat model of menopausal hot flushes. Since the peripheral ER antagonist, ICI 182,780, could completely block the effects of 8-PN, the researchers concluded that peripheral mechanisms were involved in the regulation of the vasomotor response by phytoestrogens. Previous research has shown that hops extract can strongly bind to both ERs (ERα and ERβ), stimulate alkaline phosphatase activity in Ishikawa cells, and upregulate presenelin-2 (an estrogen-inducible gene in S30 cells) and progesterone receptor mRNA in Ishikawa cells.13 All these findings suggest the estrogenic activity of hops extract. Numerous clinical trials have documented significant reductions in the frequency of hot flushes following the administration of hop-containing preparations (compared to the control group).14151718 Nevertheless, further clinical trials with larger sample size and longer follow-up are warranted to confirm such benefits. In conclusion, considering the negative effects of HRT, prenylated flavonoids extracted from hops can serve as a useful alternative treatment for the alleviation of menopausal symptoms.
  17 in total

1.  8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops and beer.

Authors:  Olaf Schaefer; Michael Hümpel; Karl-Heinrich Fritzemeier; Rolf Bohlmann; Wolf-Dieter Schleuning
Journal:  J Steroid Biochem Mol Biol       Date:  2003-02       Impact factor: 4.292

2.  A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts.

Authors:  Arne Heyerick; Stefaan Vervarcke; Herman Depypere; Marc Bracke; Denis De Keukeleire
Journal:  Maturitas       Date:  2006-05-20       Impact factor: 4.342

Review 3.  Effects of hormone replacement therapy on immunological factors in the postmenopausal period.

Authors:  F Abdi; H Mobedi; N Mosaffa; M Dolatian; F Ramezani Tehrani
Journal:  Climacteric       Date:  2016-04-18       Impact factor: 3.005

4.  Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops.

Authors:  Richard B van Breemen; Yang Yuan; Suzanne Banuvar; Lee P Shulman; Xi Qiu; René F Ramos Alvarenga; Shao-Nong Chen; Birgit M Dietz; Judy L Bolton; Guido F Pauli; Elizabeth Krause; Marlos Viana; Dejan Nikolic
Journal:  Mol Nutr Food Res       Date:  2014-09-16       Impact factor: 5.914

5.  New findings from non-linear longitudinal modelling of menopausal hormone changes.

Authors:  Lorraine Dennerstein; Philippe Lehert; Henry G Burger; Janet R Guthrie
Journal:  Hum Reprod Update       Date:  2007-07-06       Impact factor: 15.610

Review 6.  Pharmacognostic and pharmacological profile of Humulus lupulus L.

Authors:  Paola Zanoli; Manuela Zavatti
Journal:  J Ethnopharmacol       Date:  2008-01-20       Impact factor: 4.360

7.  Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment.

Authors:  J Christoffel; G Rimoldi; W Wuttke
Journal:  J Endocrinol       Date:  2006-03       Impact factor: 4.286

8.  Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature.

Authors:  Nicole Birrer; Carolina Chinchilla; Marcela Del Carmen; Don S Dizon
Journal:  Am J Clin Oncol       Date:  2018-03       Impact factor: 2.339

9.  Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms.

Authors:  Fatemeh Abdi; Farideh Kazemi; Fahimeh Ramezani Tehrani; Nasibeh Roozbeh
Journal:  BMJ Open       Date:  2016-04-22       Impact factor: 2.692

10.  Phytoestrogens impact on menopausal symptomatology.

Authors:  Semso Rosic; Sulejman Kendic; Muhamed Rosic
Journal:  Mater Sociomed       Date:  2013
View more
  13 in total

1.  Rejuvenation Using Platelet-rich Plasma and Lipofilling for Vaginal Atrophy and Lichen Sclerosus.

Authors:  Seok Hwan Kim; Eun Soo Park; Tae Hee Kim
Journal:  J Menopausal Med       Date:  2017-04-28

2.  Acacia Nilotica: New Plant for Help in Pelvic Organ Prolapse.

Authors:  Nasibeh Roozbeh; Leili Darvish
Journal:  J Menopausal Med       Date:  2016-12-31

3.  Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors.

Authors:  Dongsheng Hong; Ling Bi; Jun Zhou; Yinghui Tong; Qingwei Zhao; Jing Chen; Xiaoyang Lu
Journal:  Oncotarget       Date:  2017-06-20

Review 4.  Probiotics in the Prevention and Treatment of Postmenopausal Vaginal Infections: Review Article.

Authors:  Jun-Mo Kim; Yoo Jin Park
Journal:  J Menopausal Med       Date:  2017-12-29

Review 5.  Role Identification of Passiflora Incarnata Linnaeus: A Mini Review.

Authors:  Mijin Kim; Hee-Sook Lim; Hae-Hyeog Lee; Tae-Hee Kim
Journal:  J Menopausal Med       Date:  2017-12-29

6.  Effect of Phytoestrogen on Depression and Anxiety in Menopausal Women: A Systematic Review.

Authors:  Abolfazl Fattah
Journal:  J Menopausal Med       Date:  2017-12-29

7.  Sleep disorder, an independent risk associated with arterial stiffness in menopause.

Authors:  Yang Zhou; Ruwei Yang; Changbin Li; Minfang Tao
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

Review 8.  Beer Polyphenols and Menopause: Effects and Mechanisms-A Review of Current Knowledge.

Authors:  Berner Andrée Sandoval-Ramírez; Rosa M Lamuela-Raventós; Ramon Estruch; Gemma Sasot; Monica Doménech; Anna Tresserra-Rimbau
Journal:  Oxid Med Cell Longev       Date:  2017-08-17       Impact factor: 6.543

9.  Effect of Fennel on the Health Status of Menopausal Women: A Systematic and Meta-analysis.

Authors:  Talat Khadivzadeh; Mona Najaf Najafi; Leila Kargarfard; Masumeh Ghazanfarpour; Fatemeh Rajab Dizavandi; Imaneh Khorsand
Journal:  J Menopausal Med       Date:  2018-04-30

10.  Effect of Herbal Medicine on Vaginal Epithelial Cells: A Systematic Review and Meta-analysis.

Authors:  Yousef Rahmani; Khadijeh Chaleh Chaleh; Afshar Shahmohammadi; Shahla Safari
Journal:  J Menopausal Med       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.